The osimertinib prospect, also known as Tagrisso, is a targeted therapy medication that has gained significant attention in the field of oncology. It is primarily used in the treatment of non-small cell lung cancer (NSCLC) with mutations in the EGFR gene. This article aims to provide a comprehensive overview of the osimertinib prospect, highlighting its mechanisms of action, benefits, potential...